A once-monthly jab cuts body weight by 16% in groundbreaking obesity trial
Dual-target weight-loss drug is 47% more effective than its rival | “Our study shows that treatment with tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference."
